anmelden
AstraZeneca Aktie
150,95
EUR
-1,40
EUR
-0,92
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 02.07.15 | AstraZeneca buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.07.15 | AstraZeneca buy | UBS AG | |
| 26.06.15 | AstraZeneca Hold | HSBC | |
| 23.06.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 09.06.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 05.06.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 02.06.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 01.06.15 | AstraZeneca buy | UBS AG | |
|
Werbung
|
|||
| 27.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 27.05.15 | AstraZeneca buy | UBS AG | |
| 26.05.15 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.05.15 | AstraZeneca buy | UBS AG | |
| 26.05.15 | AstraZeneca Underweight | Barclays Capital | |
| 21.05.15 | AstraZeneca buy | Jefferies & Company Inc. | |
| 21.05.15 | AstraZeneca buy | Citigroup Corp. | |
| 14.05.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 29.04.15 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | AstraZeneca buy | Citigroup Corp. | |
| 28.04.15 | AstraZeneca buy | UBS AG | |
| 27.04.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 24.04.15 | AstraZeneca Hold | S&P Capital IQ | |
| 21.04.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 21.04.15 | AstraZeneca market-perform | Bernstein Research | |
| 21.04.15 | AstraZeneca Underweight | Barclays Capital | |
| 17.04.15 | AstraZeneca Hold | Deutsche Bank AG | |
| 16.04.15 | AstraZeneca buy | Société Générale Group S.A. (SG) | |
| 14.04.15 | AstraZeneca buy | UBS AG | |
| 13.04.15 | AstraZeneca buy | Jefferies & Company Inc. | |
| 13.04.15 | AstraZeneca buy | UBS AG | |
| 08.04.15 | AstraZeneca verkaufen | Morgan Stanley | |
| 01.04.15 | AstraZeneca Underweight | Barclays Capital | |
| 17.03.15 | AstraZeneca buy | UBS AG | |
| 17.03.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 12.03.15 | AstraZeneca buy | UBS AG | |
| 05.03.15 | AstraZeneca buy | UBS AG | |
| 25.02.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 23.02.15 | AstraZeneca buy | UBS AG | |
| 10.02.15 | AstraZeneca verkaufen | Barclays Capital | |
| 09.02.15 | AstraZeneca buy | UBS AG | |
| 06.02.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 05.02.15 | AstraZeneca Hold | S&P Capital IQ | |
| 04.02.15 | AstraZeneca buy | UBS AG | |
| 23.01.15 | AstraZeneca Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 16.01.15 | AstraZeneca Underweight | Barclays Capital | |
| 15.01.15 | AstraZeneca Hold | Deutsche Bank AG | |
| 09.01.15 | AstraZeneca buy | UBS AG | |
| 05.01.15 | AstraZeneca Neutral | JP Morgan Chase & Co. | |
| 15.12.14 | AstraZeneca Neutral | Goldman Sachs Group Inc. | |
| 09.12.14 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 03.12.14 | AstraZeneca Underweight | Morgan Stanley | |
Werbung
Werbung